CSPC Pharmaceutical Group Limited (1093.HK)
HKD 4.79
(0.84%)
HKD 4.79
(0.84%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 12.02 Billion HKD | 8.68% |
| 2022 | 11.06 Billion HKD | 18.06% |
| 2021 | 9.37 Billion HKD | 17.74% |
| 2020 | 7.96 Billion HKD | 7.11% |
| 2019 | 7.43 Billion HKD | -3.11% |
| 2018 | 7.67 Billion HKD | 49.65% |
| 2017 | 5.12 Billion HKD | 25.32% |
| 2016 | 4.09 Billion HKD | 3.35% |
| 2015 | 3.95 Billion HKD | 13.81% |
| 2014 | 3.47 Billion HKD | -3.31% |
| 2013 | 3.59 Billion HKD | -35.58% |
| 2012 | 5.58 Billion HKD | 40.36% |
| 2011 | 3.97 Billion HKD | 21.48% |
| 2010 | 3.27 Billion HKD | 2.52% |
| 2009 | 3.19 Billion HKD | 9.27% |
| 2008 | 2.92 Billion HKD | 366.45% |
| 2007 | 626.75 Million HKD | -76.17% |
| 2006 | 2.62 Billion HKD | -12.41% |
| 2005 | 3 Billion HKD | 15.58% |
| 2004 | 2.59 Billion HKD | 97.78% |
| 2003 | 1.31 Billion HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 12.27 Billion HKD | 0.0% |
| 2023 FY | 12.02 Billion HKD | 8.68% |
| 2023 Q4 | 12.02 Billion HKD | 0.0% |
| 2023 Q2 | 10.16 Billion CNY | 0.0% |
| 2022 Q4 | 11.06 Billion HKD | 0.0% |
| 2022 Q2 | 11.04 Billion HKD | 0.0% |
| 2022 FY | 11.06 Billion HKD | 18.06% |
| 2021 FY | 9.37 Billion HKD | 17.74% |
| 2021 Q2 | 9.07 Billion HKD | 0.0% |
| 2021 Q4 | 9.37 Billion HKD | 0.0% |
| 2020 FY | 7.96 Billion HKD | 7.11% |
| 2020 Q4 | 7.96 Billion HKD | 0.0% |
| 2020 Q2 | 9.1 Billion HKD | 0.0% |
| 2019 Q2 | 7.51 Billion HKD | 0.0% |
| 2019 FY | 7.43 Billion HKD | -3.11% |
| 2019 Q4 | 7.43 Billion HKD | 0.0% |
| 2018 Q2 | 7.75 Billion HKD | 0.0% |
| 2018 FY | 7.67 Billion HKD | 49.65% |
| 2018 Q4 | 7.67 Billion HKD | 0.0% |
| 2018 Q3 | - HKD | -100.0% |
| 2017 Q1 | - HKD | -100.0% |
| 2017 Q4 | 5.12 Billion HKD | 0.0% |
| 2017 FY | 5.12 Billion HKD | 25.32% |
| 2017 Q2 | 4.83 Billion HKD | 0.0% |
| 2016 Q1 | - HKD | -100.0% |
| 2016 FY | 4.09 Billion HKD | 3.35% |
| 2016 Q4 | 4.09 Billion HKD | 0.0% |
| 2016 Q2 | 4.38 Billion HKD | 0.0% |
| 2015 Q2 | 4.24 Billion HKD | 0.0% |
| 2015 FY | 3.95 Billion HKD | 13.81% |
| 2015 Q4 | 3.95 Billion HKD | 0.0% |
| 2015 Q1 | - HKD | -100.0% |
| 2014 Q2 | 3.69 Billion HKD | 0.0% |
| 2014 Q1 | - HKD | -100.0% |
| 2014 Q3 | - HKD | -100.0% |
| 2014 FY | 3.47 Billion HKD | -3.31% |
| 2014 Q4 | 3.47 Billion HKD | 0.0% |
| 2013 FY | 3.59 Billion HKD | -35.58% |
| 2013 Q4 | 3.59 Billion HKD | 0.0% |
| 2013 Q1 | - HKD | -100.0% |
| 2013 Q3 | - HKD | -100.0% |
| 2013 Q2 | 4.55 Billion HKD | 0.0% |
| 2012 Q3 | - HKD | -100.0% |
| 2012 Q4 | 5.58 Billion HKD | 0.0% |
| 2012 FY | 5.58 Billion HKD | 40.36% |
| 2012 Q2 | 3.69 Billion HKD | 0.0% |
| 2012 Q1 | - HKD | -100.0% |
| 2011 Q4 | 3.97 Billion HKD | 0.0% |
| 2011 Q2 | 3.64 Billion HKD | 0.0% |
| 2011 FY | 3.97 Billion HKD | 21.48% |
| 2010 Q4 | 3.27 Billion HKD | 0.0% |
| 2010 Q2 | 3.29 Billion HKD | 0.0% |
| 2010 FY | 3.27 Billion HKD | 2.52% |
| 2009 Q4 | 3.19 Billion HKD | 0.0% |
| 2009 FY | 3.19 Billion HKD | 9.27% |
| 2008 FY | 2.92 Billion HKD | 366.45% |
| 2007 FY | 626.75 Million HKD | -76.17% |
| 2006 FY | 2.62 Billion HKD | -12.41% |
| 2005 FY | 3 Billion HKD | 15.58% |
| 2004 FY | 2.59 Billion HKD | 97.78% |
| 2003 FY | 1.31 Billion HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|